XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma
Status:
Not yet recruiting
Trial end date:
2025-01-30
Target enrollment:
Participant gender:
Summary
To observe and evaluate the efficacy and safety of oxaliplatin with
oapecitabine（XELOX）combined with apatinib as post-operative chemotherapy in locally advanced
gastric adenocarcinoma with D2 dissection